About this trial
This multicenter randomized controlled trial evaluates the effect of first-visit foam sclerotherapy (including sub-ulcer foam sclerotherapy) in patients with venous leg ulcer.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient informed consent
Venous ulcer, aged from one month to one year
Duplex ultrasonography verified (vein reflux greater than >0.5 second) superficial venous insufficiency
Sufficient arterial circulation (at least on criterion met: Palpable distal pulses / ankle-brachial index > 0,8 / Toe pressure >60mmhg)
Disqualifiers
Leg ulcers other than venous etiology
Ulcers requiring operation theater revision
Patent foramen ovale
Several times recurrent (over 3 recurrences) venous ulcer
Trial design
Parallel
Treatments tested in this trial
Endothermal Ablation
Procedure/SurgeryEndothermal ablation is performed to suitable insufficient truncal veins (Great-, Anterior Accessory- and/or Small Saphenous Vein)
Foam Sclerotherapy
Procedure/SurgeryFoam sclerotherapy is performed to insufficient veins distal to the truncal superficial veins.
Treatment groups
Trial outcomes
Primary outcomes
Time to ulcer Healing
Complete re-epithelialisation of ulcer area
Secondary outcomes
EQ-5D Questionnaire
Score 0-100 where higher is better
Wound-QOL Questionnaire
Score 0-17 where lower is better
Venous ulcer area
Reduction on venous ulcer maximum diameter
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Oulu University Hospital
Lead sponsor
Helsinki University Central Hospital
Collaborator